Brian Lian's Sale of Performance Stock Units in Viking Therapeutics, Inc.

Brian Lian, an officer of Viking Therapeutics, Inc., has filed a Form 144 notice indicating the sale of 38,989 common stock units. These units were acquired as Performance Stock Units on October 27, 2025, and are scheduled to be sold on October 28, 2025. The aggregate market value of the securities to be sold is approximately $1,364,923.01. The sale will be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The filing also confirms that there have been no other sales of securities by Lian in the past three months.